This article on R&D tax relief has it all: wins, losses, systemic rises and falls, whistleblowing and (of course) compliance.

Stepping into June, I’ve been wondering if my usual “glass half full” outlook is taking a hit. My recent conversation with Paul Rosser regarding R&D tax relief, which included everything from systemic improvements to compliance and whistleblowing, along with our follow-up discussions on LinkedIn, has proven to be both enlightening and challenging. This newsletter explores those main themes, the perspectives exchanged, and some remaining questions.
One of the biggest surprises for me was Paul's statement that he would keep many aspects the same if given a blank slate to develop a new R&D scheme. A point that also seemed to resonate with a lot of you. Rather than going over the list again, I'll link the post where I provided the breakdown.
A popular idea, echoed by commentators like Malcolm Henderson , was a call to “bring back HMRC R&D Unit” or regional advisors. The thinking is that this could reduce fraud, improve customer service, and give consultants back a direct line for queries. As Stephen Gibbens noted, regional advisors could mean more efficient and cost-effective claims for genuine innovators, reminiscent of a past system with a closer relationship with HMRC. Ironically, we could argue that the closing down of this process was a cost-cutting measure, but in the end, it's more costly to fight R&D fraud without having a more efficient channel of communication with HMRC.
Asking the above question naturally led to a deeper dive into how we arrived at our current situation. In my follow-up post, exploring what went wrong with the R&D tax relief scheme, where Paul highlighted that “any system which relies on putting a claim in without it being checked and paid out anyways is prone to failure”, Chris Williams raised a new perspective: should companies self-assess their innovation?
I’ve always considered myself an optimistic realist. But the constant news of R&D fraud in the UK had me feeling ... well, cynical. When I suggested to Paul that a simple R&D scheme might no longer be viable, he countered that “simple isn’t always bad”. He also made a crucial point when I compared the UK to stricter systems: consider the sheer volume of claims in the UK. More stringent rules are much harder to manage with tens of thousands of applications. It’s a valuable perspective to keep in mind as you continue reading.
While the definition of what is R&D for tax purposes is largely similar abroad, the approach to self-assessment versus upfront validation varies significantly. If you’re curious about a detailed comparison of relief rates and scheme transparency across the globe, Tim Walsh wrote a great article.
A Quick Disclaimer: My knowledge of international R&D schemes was previously nonexistent. I’ve done my best to verify the information below. Luckily, after sharing my little conundrum about the upcoming topic on international R&D schemes with Simon Bulteel, he put me in contact with Jean-Georges Fisher , who is incredibly knowledgeable about various European R&D schemes and who I was fortunate to have a call with to discuss them. I was also later able to speak with Rory O'Shea and ask about the Irish scheme.
Although I’ve done my best to provide the most accurate information, I may have made mistakes. If you spot any errors, please let me know so I can correct them.
Here's what caught my attention:
Germany: no claim without prior approval. An independent body first assesses whether a technical project is genuine R&D. If approved, the company can then claim tax relief. This system prioritises technical validation before the financial claim. Obtaining a certification does not automatically guarantee an unconditional payout.
France: operates on self-assessment but has an interesting advance approval option (rescrit fiscal), though many don’t utilise it, opting to 'chance it' instead. However, selecting the advanced approval option typically provides a binding agreement with the authorities on the eligibility of your innovation, which effectively acts as a guarantee, provided the calculations are also accurate, and usually takes 90 days.
This process appears to be similar to that of the UK’s Advance Assurance, although without the eligibility limits and less strongly binding on the tax authority than the rescrit fiscal in France.
Spain: offers a generous R&D tax credit with a compelling incentive for pre-certification. While also optional, getting your R&D project approved via Ministry-approved certification bodies means your claim is processed (significantly) faster, and you can offset 100% of your corporation tax (versus 50% without it). There are clearly two very strong incentives, both financially and time-wise, to do this, thereby encouraging upfront validation.
Ireland: claims are self-assessed and submitted via the corporation tax return. There is a pre-notification requirement, which is 90 days prior to submitting your return. Failure to do so will disqualify your claim. Although a step to add more oversight, it can be seen as a 'hindrance'; however, the timeframe is much more flexible and easier to understand than the UK's equivalent pre-notification requirement.
There is no way to add an R&D report to the corporation tax return, meaning you will only be required to provide documentation if Revenue investigates. Although there’s also a chance they won’t, when they do, it involves extensive science tests and accounting tests involving their own technical experts trying to validate the nature of your R&D and match costs, so meticulous record-keeping is crucial even if not required for submission.
While self-assessment is common, many countries complement it with upfront validation, whether it's mandatory (Germany), incentivised (France, Spain) or through robust potential for post-claim scrutiny (Ireland).
The core tension seems always to toe the line between making the scheme accessible and minimising administrative burden. In the UK, the Additional Information Form and Claim Notification Form were clearly a step towards providing more upfront detail; however, the timeframe for submitting the Claim Notification Form arguably reduced accessibility due to missed deadlines.
It seems that if the overall rate of an inquiry is low, many will “chance it” rather than seek optional pre-approval, even if it offers certainty. Why are businesses not willing to go that extra mile?
For me, Spain’s model, with its powerful financial incentive for getting pre-approval, is definitely intriguing. Could a similar approach have worked in the UK? Instead of merging the SME and RDEC schemes and substantially slashing the benefits due to supposed fraud in the former, what if we had kept both schemes but offered an optional certification route for SMEs, leading to the 2022 rate being applied? This would also address the scalability concerns that Paul raised, which create a disadvantage for countries like the UK with a large number of claims to process.
I guess the question still remains: is the self-assessment model outdated and inherently more vulnerable? And if we do add more scrutiny, how much is enough to prevent abuse without making the process too slow or complex, especially in a high-volume system like the UK?
Our discussion about a “snitching hotline” was probably one of the more controversial ones. Should we encourage snitching to facilitate accountability, or does it only breed mistrust?
The US R&D scheme has one, but it appears that what is being considered in the UK is more akin to whistleblowing, where R&D agents or employees report potential wrongdoing. While the intent - to provide a mechanism for reporting malpractice - appears noble, it can be a slippery slope, which I explained in the video here. However, I need to make a distinction that I am specifically talking about the concept of 'snitching', especially when there are financial incentives. Having proper channels to report fraud is necessary and needed.
Chris Worden seems not to have caught my earlier cynicism bug and suggested, “clear guidance from HMRC would be more effective than a reporting system.” This shifts the focus from policing towards empowerment through understanding. But are we past the point where guidance alone is enough? Malicious advisors will ignore it, and will busy companies look into R&D legislation before agreeing to make a claim from a charismatic swindler? Would those nurseries have read through HMRC’s guidance before accepting a much-needed tax break? I’m not sure, but that could be the glass half empty in me talking.
Paul’s take was blunt, “you’ve got to give people a deterrent, show there’s a consequence. I wouldn’t go rob a bank because I'd probably end up in prison. It should be the same thing for people promoting tax avoidance”. His words highlight the seriousness of the exploitation we’ve seen in the UK market. It brings us full circle, from tinkering with the system to the stark reality of consequences. We’re wrestling with policy design, human behaviour, and the constant tension between fostering innovation and protecting the public purse. Are we close to a resolution, or is this conversation far from over?
Our co-founder, Tom Elsbury , was featured on the Get Started Media podcast, where he discussed the journey of creating Novel. He shared significant moments, important insights, and the motivations behind our work, offering a deeper understanding of both himself and the business. If you're interested in learning more, you can listen here.